Results 211 to 220 of about 914,658 (345)
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
How Clinical Pharmacology Can Support Clinical Trial Diversity and Inclusion. [PDF]
Liao MZ +7 more
europepmc +1 more source
Training in paediatric clinical pharmacology in the UK [PDF]
Imti Choonara +8 more
openalex +1 more source
Expanding Precompetitive Multisector Collaborations to Advance Drug Development and Pharmacogenomics. [PDF]
Do, Thao P +7 more
core +2 more sources
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli +8 more
wiley +1 more source
Subcutaneous Estradiol Pellets as Hormone Therapy in Menopause: Clinical Pharmacology, Patient Selection and Safety Considerations. [PDF]
Jacobsen L +4 more
europepmc +1 more source
Erratum to Vinorelbine: a review of its pharmacological properties and clinical use in cancer chemotherapy [PDF]
Karen L. Goa, Diana Faulds
openalex +1 more source
Objective Reports have linked both high and low serum uric acid (SUA) levels to adverse health outcomes. This study aimed to establish a reference interval for SUA in older adults and assessed its association with clinically relevant outcomes in relatively healthy, community‐dwelling individuals aged ≥70 years old.
Amanda J. Rickard +15 more
wiley +1 more source

